Evidence map›Paper›PMID 40226372›Full record

ArticleClinical kidney journal2025

Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003-21.

Laia Oliveras, Laura Pareja, Josepa Ribes, Jordi Comas, Carlos Couceiro, Àlex Favà, Sergi Codina, Ana Coloma, Anna Manonelles, Nuria Lloberas and 8 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Laia OliverasHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.ORCID https://orcid.org/0009-0002-5317-7304
Laura ParejaHospital Cancer Registry Unit, Catalan Institute of Oncology, Barcelona, Spain.
Josepa RibesHospital Cancer Registry Unit, Catalan Institute of Oncology, Barcelona, Spain.
Jordi ComasCatalan Transplant Organization, Department of Health of Catalonia, Barcelona, Spain.
Carlos CouceiroHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.ORCID https://orcid.org/0000-0002-8303-8703
Àlex FavàHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.
Sergi CodinaHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.
Ana ColomaHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.
Anna ManonellesHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.ORCID https://orcid.org/0000-0003-2456-388X
Nuria LloberasBiomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain.
Edoardo MelilliHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.ORCID https://orcid.org/0000-0001-6965-3745
Elisenda Martinez-CarbonellAgency for Health Quality and Assessment of Catalonia, Department of Health of Catalonia, Barcelona, Spain.
Jordi GálvezHospital Cancer Registry Unit, Catalan Institute of Oncology, Barcelona, Spain.
Sonia MosteiroHospital Cancer Registry Unit, Catalan Institute of Oncology, Barcelona, Spain.
Jaume TortCatalan Transplant Organization, Department of Health of Catalonia, Barcelona, Spain.
Josep M BorràsCatalan Pathology Registry, Catalan Cancer Plan, Department of Health of Catalonia, Barcelona, Spain.
Josep M CruzadoHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.
Nuria MonteroHospital Universitari de Bellvitge, Nephrology Department, L'Hospitalet de Llobregat, Spain.ORCID https://orcid.org/0000-0002-5123-4603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People with kidney failure have a higher risk of cancer compared with age- and sex-matched individuals in the general population, yet data from southern Europe are limited. This study explores cancer incidence in the kidney failure population in Catalonia. Methods: We identified cancer cases through linkage of the Catalan Kidney Registry with Catalan cancer databases. Standardized incidence ratios (SIRs) were calculated for all-site and site-specific cancers in people on dialysis and kidney transplant recipients. Results: We described the epidemiology of cancer in 21 595 people on dialysis and 8037 kidney transplant recipients in Catalonia (2003-21). Cancer risk was more than two times higher in people on dialysis (SIR 2.11, 95% CI 2.02-2.19) and nearly four times higher in kidney transplant recipients (SIR 3.82, 95% CI 3.65-3.99) compared with the general population. Risks varied by cancer site, with a significantly higher incidence of kidney and thyroid cancers in the dialysis cohort, and skin cancer in the transplant cohort. The highest cancer risks were observed in the youngest, those with glomerular diseases, and those with the longest time since transplantation. Conclusions: People with kidney failure face a high burden of cancer, particularly after kidney transplantation. Understanding the epidemiology of cancer in the kidney failure population is crucial for shaping health policies.

Indexed as

cancer epidemiologycancer risksdialysiskidney failurekidney transplant

Identifiers

PMID40226372
PMCPMC11986820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.